Roth Capital Partners is acting as manager.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BPTH:
- Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia
- Bio-Path completes first doses cohort of Phase 1/1b trial of BP1002
- Bio-Path Holdings Reports Third Quarter 2023 Financial Results
- Bio-Path reports Q3 EPS (32c) vs (49c) last year
- Is BPTH a Buy, Before Earnings?